US biotech Biogen has received US Food and Drug Administration (FDA) Breakthrough Therapy designation for salanersen, its ...

Russia will have its own generic of one of the world’s most expensive drug against cystic fibrosis, as the Russian ...

US biotech Stipple Bio has signed a multi-target licensing agreement with Swiss life sciences supplier Lonza to support ...

UK privately-held AMR Bio has submitted written comments to the Presidential Advisory Council on Combating ...

The 2026 American Society of Clinical Oncology (ASCO) annual meeting delivered several potentially practice-changing datasets ...

Israel-headquartered Teva Pharmaceutical Industries has announced the launch of Ahzantive (aflibercept), a biosimilar to ...

Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, ...

US drugmaker Gilead Sciences today announced that the UK’s National Institute for Health and Care Excellence (NICE) has ...

Australian clinical-stage biotech Neurizon Therapeutics (ASX: NUZ; OTCQB: NUZTF) is expanding the NUZ-001 arm of the HEALEY ...

Belgian biopharma UCB (Euronext Brussels: UCB) and US biotech Biogen (Nasdaq: BIIB) have reported further Phase III data for ...

A Shanghai-based biopharmaceutical company commercializing rare kidney and autoimmune treatments across Greater China and ...

Shares of US biopharma company Cingulate closed up 11.9% at $4.03 on Tuesday, after it announced that the US Food and Drug ...